Elanco Animal Health Incorporated has announced the availability of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) for veterinarians. This product is designed to provide comprehensive protection against six types of parasites, making it the first monthly chewable tablet to do so. The targeted parasites include tapeworms, roundworms, hookworms, heartworms, fleas, and ticks.
Read More
Bobby Modi, Executive Vice President of U.S. Pet Health and Global Digital Transformation, stated that the launch is significant as it meets the needs of pet owners who prioritize intestinal worm treatment. A survey indicated that 94% of dog owners view proactive treatment for intestinal worms as essential, with product effectiveness and duration of protection being top concerns. However, only one in three respondents recognize the year-round risk of fleas and ticks.
Credelio Quattro is formulated to be a convenient option for pet owners, with proven efficacy against tapeworms and superior speed in eliminating ticks compared to other products on the market. Dr. Casey Locklear, a veterinarian at Elanco, emphasized the necessity of year-round parasite prevention, especially in regions where certain tapeworms are common.
Veterinarians can place orders for Credelio Quattro at CredelioQuattroVet.com, and it will debut at the Veterinary Meeting & Expo (VMX) in Orlando from January 25-29, 2025.
Credelio Quattro is part of Elanco's ongoing commitment to animal health, providing innovative solutions while aiming to improve the health of pets and the communities they belong to. The product is specifically aimed at dogs and puppies aged eight weeks and older, weighing 3.3 pounds or more, and is meant to prevent heartworm disease as well as treat and control various worm infections.
Elanco has a long history in animal health and continues to focus on enhancing both animal health and the welfare of farmers and pet owners.